KellyAnn D. Pryor

822 total citations
14 papers, 606 citations indexed

About

KellyAnn D. Pryor is a scholar working on Oncology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, KellyAnn D. Pryor has authored 14 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in KellyAnn D. Pryor's work include Peptidase Inhibition and Analysis (9 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (5 papers). KellyAnn D. Pryor is often cited by papers focused on Peptidase Inhibition and Analysis (9 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (5 papers). KellyAnn D. Pryor collaborates with scholars based in United States and New Zealand. KellyAnn D. Pryor's co-authors include Barbara Leiting, Joseph K. Wu, Nancy A. Thornberry, Reshma A. Patel, Frank Marsilio, Jonathan A. Ellman, Charles S. Craik, Richard Cummings, George J. Eiermann and Kalpit A. Vora and has published in prestigious journals such as Analytical Biochemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

KellyAnn D. Pryor

14 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
KellyAnn D. Pryor United States 10 305 240 178 145 74 14 606
James G. Robertson United States 15 465 1.5× 63 0.3× 21 0.1× 81 0.6× 292 3.9× 26 865
Roberto Bessalle Israel 12 585 1.9× 101 0.4× 71 0.4× 23 0.2× 56 0.8× 14 798
Emil Schiltz Germany 15 462 1.5× 46 0.2× 54 0.3× 77 0.5× 24 0.3× 25 666
Christopher W. Kemp United States 7 411 1.3× 259 1.1× 96 0.5× 8 0.1× 81 1.1× 12 644
Juan Pablo Maianti Canada 12 1.0k 3.4× 58 0.2× 23 0.1× 32 0.2× 185 2.5× 16 1.2k
Maria Kontou Greece 15 411 1.3× 47 0.2× 16 0.1× 24 0.2× 193 2.6× 28 621
Stella H. Wilkes United States 14 384 1.3× 382 1.6× 199 1.1× 17 0.1× 56 0.8× 20 658
Catherine Luxford Australia 12 269 0.9× 107 0.4× 14 0.1× 63 0.4× 44 0.6× 27 666
Michael A. Hast United States 12 479 1.6× 132 0.6× 46 0.3× 13 0.1× 114 1.5× 20 668
Carl L. Zimmerman United States 5 532 1.7× 48 0.2× 51 0.3× 33 0.2× 47 0.6× 6 792

Countries citing papers authored by KellyAnn D. Pryor

Since Specialization
Citations

This map shows the geographic impact of KellyAnn D. Pryor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KellyAnn D. Pryor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KellyAnn D. Pryor more than expected).

Fields of papers citing papers by KellyAnn D. Pryor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KellyAnn D. Pryor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KellyAnn D. Pryor. The network helps show where KellyAnn D. Pryor may publish in the future.

Co-authorship network of co-authors of KellyAnn D. Pryor

This figure shows the co-authorship network connecting the top 25 collaborators of KellyAnn D. Pryor. A scholar is included among the top collaborators of KellyAnn D. Pryor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KellyAnn D. Pryor. KellyAnn D. Pryor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Zhao, Xuemei, Katie Southwick, Helene L. Cardasis, et al.. (2010). Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase. PROTEOMICS. 10(15). 2882–2886. 8 indexed citations
3.
Zhou, Changyou, Shirly Pinto, Zhe Feng, et al.. (2010). Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity. Journal of Medicinal Chemistry. 53(19). 7251–7263. 36 indexed citations
4.
Vora, Kalpit A., Gene Porter, Yan Cui, et al.. (2009). Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses. BMC Immunology. 10(1). 19–19. 43 indexed citations
5.
Kim, Dooseop, Scott D. Edmondson, Anthony Mastracchio, et al.. (2007). Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate). Bioorganic & Medicinal Chemistry Letters. 17(12). 3373–3377. 39 indexed citations
6.
Leiting, Barbara, KellyAnn D. Pryor, Frank Marsilio, et al.. (2007). Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5934–5939. 32 indexed citations
7.
Leiting, Barbara, et al.. (2006). Inhibition of Dipeptidyl-Peptidase IV Does Not Increase Circulating IGF-1 Concentrations in Growing Pigs. Experimental Biology and Medicine. 231(8). 1373–1378. 10 indexed citations
8.
Pryor, KellyAnn D., et al.. (2003). Purification, crystallization and preliminary X-ray analysis ofEscherichia coliUDP-N-acetylmuramoyl:L-alanine ligase (MurC). Acta Crystallographica Section D Biological Crystallography. 59(8). 1510–1513. 1 indexed citations
9.
Leiting, Barbara, KellyAnn D. Pryor, Joseph K. Wu, et al.. (2003). Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII. Biochemical Journal. 371(2). 525–532. 150 indexed citations
10.
Hammond, Gail G., Joann Huber, Mark L. Greenlee, et al.. (1999). Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiology Letters. 179(2). 289–296. 42 indexed citations
11.
O’Connell, Juliette, KellyAnn D. Pryor, Stephan K. Grant, & Barbara Leiting. (1999). A high quality nuclear magnetic resonance solution structure of peptide deformylase from Escherichia coli: Application of an automated assignment strategy using GARANT. Journal of Biomolecular NMR. 13(4). 311–324. 9 indexed citations
12.
Toney, Jeffrey H., Gail G. Hammond, Barbara Leiting, et al.. (1998). Soluble Penicillin-Binding Protein 2a: β-Lactam Binding and Inhibition by Non-β-Lactams Using a 96-Well Format. Analytical Biochemistry. 255(1). 113–119. 13 indexed citations
13.
Leiting, Barbara, KellyAnn D. Pryor, Suzanne S. Eveland, & Matt S. Anderson. (1998). One-Day Enzymatic Synthesis and Purification of UDP–N- [1-14C]Acetyl-Glucosamine. Analytical Biochemistry. 256(2). 185–191. 13 indexed citations
14.
Pryor, KellyAnn D. & Barbara Leiting. (1997). High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System. Protein Expression and Purification. 10(3). 309–319. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026